The Pennant Group, Inc. (PNTG)
NASDAQ: PNTG · IEX Real-Time Price · USD
27.14
+0.24 (0.89%)
At close: Jul 19, 2024, 4:00 PM
27.24
+0.10 (0.37%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
The Pennant Group Market Cap
The Pennant Group has a market cap or net worth of $815.44 million as of July 22, 2024. Its market cap has increased by 144.58% in one year.
Market Cap
815.44M
Enterprise Value
1.16B
1-Year Change
144.58%
Ranking
Category
Stock Price
$27.14
Market Cap Chart
Since October 1, 2019, The Pennant Group's market cap has increased from $422.50M to $815.44M, an increase of 93.00%. That is a compound annual growth rate of 14.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 815.40M | 95.73% |
| Dec 29, 2023 | 416.60M | 27.87% |
| Dec 30, 2022 | 325.80M | -50.43% |
| Dec 31, 2021 | 657.30M | -59.84% |
| Dec 31, 2020 | 1.64B | 77.73% |
| Dec 31, 2019 | 920.90M | 117.96% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InnovAge Holding | 825.45M |
| Mesoblast | 825.11M |
| Cogent Biosciences | 823.23M |
| CureVac | 823.20M |
| 89bio | 821.51M |
| Standard BioTools | 811.22M |
| Clover Health Investments | 809.19M |
| Cytek Biosciences | 807.33M |